ConductScience.org, home

Paper36135

Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.

Williams JW and 2 others. Biochemistry, 1979. Cited by 226 papers, by iCite.

Cite this record

ConductScience Library. Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase. Papers, record 36135. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36135

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methotrexate, a high-affinity pseudosubstrate of dihydrofolate reductase.
PubMed
Journal
Biochemistry
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
226
iCite
Relative citation ratio, by iCite
6.24
iCite
Revised in PubMed
2019-06-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Williams JWJ W
2Morrison JFJ F
3Duggleby RGR G

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethotrexateMajor topic
StreptococcusMajor topic
Tetrahydrofolate DehydrogenaseMajor topic
Kinetics
Mathematics
NADP
Oxidation-Reduction
Protein Binding

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 226 citations.

PMIDTitleJournalYearIn PapersSource
41959532Microbial metabolism of methotrexate produces a STAT3 signaling molecule that alleviates gut inflammation.bioRxiv2026https://conductscience.org/library/papers/41959532PubMed
41509643A new compound that extends the lifespan of worms, with favorable in vitro properties and a lack of toxicity in rodents.RSC Med Chem2026https://conductscience.org/library/papers/41509643PubMed
41003927Propeptide-mediated enhancement of hyperthermophilic subtilisin-like protease expression in Escherichia coli.AMB Express2025https://conductscience.org/library/papers/41003927PubMed
37875111Methotrexate-based PROTACs as DHFR-specific chemical probes.Cell Chem Biol2024https://conductscience.org/library/papers/37875111PubMed
37655909High selectivity of the hyperthermophilic subtilase propeptide domain toward inhibition of its cognate protease.Microbiol Spectr2023https://conductscience.org/library/papers/37655909PubMed
36627750One-carbon metabolic enzymes are regulated during cell division and make distinct contributions to the metabolome and cell cycle progression in Saccharomyces cerevisiae.G3 (Bethesda)2023https://conductscience.org/library/papers/36627750PubMed
34660967Effects of Distal Mutations on Ligand-Binding Affinity in E. coli Dihydrofolate Reductase.ACS Omega2021https://conductscience.org/library/papers/34660967PubMed
34104654A Role for Folate in Microbiome-Linked Control of Autoimmunity.J Immunol Res2021https://conductscience.org/library/papers/34104654PubMed
32251371Directional conformer exchange in dihydrofolate reductase revealed by single-molecule nanopore recordings.Nat Chem2020https://conductscience.org/library/papers/32251371PubMed
31303985Revitalizing antifolates through understanding mechanisms that govern susceptibility and resistance.Medchemcomm2019https://conductscience.org/library/papers/31303985PubMed
30192413Chemical space of Escherichia coli dihydrofolate reductase inhibitors: New approaches for discovering novel drugs for old bugs.Med Res Rev2019https://conductscience.org/library/papers/30192413PubMed
28819543Diosmin Attenuates Methotrexate-Induced Hepatic, Renal, and Cardiac Injury: A Biochemical and Histopathological Study in Mice.Oxid Med Cell Longev2017https://conductscience.org/library/papers/28819543PubMed
28525268Rational Design of Novel Allosteric Dihydrofolate Reductase Inhibitors Showing Antibacterial Effects on Drug-Resistant Escherichia coli Escape Variants.ACS Chem Biol2017https://conductscience.org/library/papers/28525268PubMed
28349498Halophilic mechanism of the enzymatic function of a moderately halophilic dihydrofolate reductase from Haloarcula japonica strain TR-1.Extremophiles2017https://conductscience.org/library/papers/28349498PubMed
26414808
Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.
Eur J Med Chem2015https://conductscience.org/library/papers/26414808PubMed
25703118
Insights into the slow-onset tight-binding inhibition of Escherichia coli dihydrofolate reductase: detailed mechanistic characterization of pyrrolo [3,2-f] quinazoline-1,3-diamine and its derivatives as novel tight-binding inhibitors.
FEBS J2015https://conductscience.org/library/papers/25703118PubMed
24820793Protein mass-modulated effects in the catalytic mechanism of dihydrofolate reductase: beyond promoting vibrations.J Am Chem Soc2014https://conductscience.org/library/papers/24820793PubMed
24347635Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/24347635PubMed
23155486Mechanistic and structural basis for inhibition of thymidylate synthase ThyX.Open Biol2012https://conductscience.org/library/papers/23155486PubMed
22234658Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate.Photochem Photobiol Sci2012https://conductscience.org/library/papers/22234658PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36135

GET https://conductscience.org/api/papers/v1/36135/cited_by?page=2